IP Library Granted Patent US 9,078,992
Granted Patent B2
US 9,078,992 · App. 13/915,605 · Granted Jul 14, 2015

Medical device for applying antimicrobial to proximal end of catheter

Inventors: Robert J. Ziebol (Maple Grove, MN); Keith J. Modert (Maple Grove, MN)
Assignee: Pursuit Vascular, Inc.
A61M25/0017A61L2/186A61L29/16A61M25/0043A61M39/20A61L2202/24A61L2300/206A61L2300/404A61M5/001A61M39/162A61M2025/0018A61M2025/0019A61M2025/0056A61M2209/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,078,992
App. No.
13/915,605
Granted
Jul 14, 2015
Kind
B2
Abstract

Systems, methods, and articles for providing an antimicrobial composition to the proximal elements of a trans-dermal catheter and into the lumen of the transdermal catheter are disclosed. In an embodiment, an antimicrobial composition on surface a cap element transfers antimicrobial to the proximal end of the transdermal catheter. The system comprises an elongate member configured for insertion into a lumen of a catheter, the elongate member containing an antimicrobial.

Claims (52)

1. A device for insertion into a hub on a proximal end of a transdermal catheter to provide antimicrobial properties, the device comprising:

a) a cap configured to be removably secured to the hub, the cap comprising:

i) an outer surface for handling the device, and

ii) an inner volume having an interior surface, the interior surface containing threads configured to engage threads on the hub;

b) a tapered member positioned at least partially within the inner volume of the cap, such that the tapered member is located opposite the threads on the cap; and

c) an elongate member secured to the tapered member and configured for insertion into the hub, the elongate member comprising an antimicrobial agent;

wherein the tapered member and elongate member are configured for insertion into the hub such that antimicrobial agent from the elongate member is delivered into the hub proximal to a clamp, the clamp on a proximal portion of the transdermal catheter that is distal from the hub; and

wherein the elongate member is configured for insertion into the hub while the clamp is closed and is retained substantially within the hub, and upon insertion into the hub, is configured to direct liquids (i) radially away from the elongate member, (ii) toward the threads on the hub and (iii) not distal to the clamp when the clamp is closed.

2. The device of claim 1 , wherein the elongate member is less than 25 millimeters long.

3. The device of claim 1 , wherein the elongate member is less than 2.5 millimeters wide.

4. The device of claim 1 , wherein the elongate member is substantially rigid.

5. The device of claim 1 , wherein the elongate member is sufficiently self-supporting to maintain its shape under its own weight.

6. The device of claim 1 , wherein the tapered member has a taper of at least 5 percent.

7. The device of claim 1 , wherein the threads on the cap comprise an antimicrobial agent.

8. The device of claim 1 , wherein the tapered member comprises an antimicrobial agent.

9. A device for insertion into a hub on a proximal end of a transdermal catheter to provide antimicrobial properties, the device comprising:

a) a cap configured to be removably secured to the hub on the proximal end of the transdermal catheter;

b) a tapered member secured to an interior of the cap; and

c) a substantially rigid elongate member secured to the tapered member and configured for insertion into the hub of the transdermal catheter, the elongate member comprising an antimicrobial agent;

wherein the tapered member and the elongate member are configured for insertion into the hub on the proximal end of the transdermal catheter proximal to a clamp, the clamp on a proximal portion of the transdermal catheter that is distal from the hub, such that the antimicrobial agent from the elongate member is delivered into the hub located on the proximal end of the transdermal catheter; and

wherein the elongate member is configured for insertion into the transdermal catheter while the clamp is closed and is retained substantially within the hub, and upon insertion into the hub of the transdermal catheter, the elongate member is configured to direct liquids (i) radially away from the elongate member, (ii) toward threads on the hub of the transdermal catheter and (iii) proximal to the clamp; but not distal to the clamp.

10. The device of claim 9 , wherein the elongate member is less than 25 millimeters long.

11. The device of claim 9 , wherein the elongate member is less than 2.5 millimeters wide.

12. The device of claim 9 , wherein the elongate member is sufficiently self-supporting to maintain its shape under its own weight.

13. The device of claim 9 , wherein the tapered member has a taper of at least 5 percent.

14. The device of claim 9 , wherein the tapered member comprises an antimicrobial agent.

15. A device for insertion into a hub on a proximal end of a transdermal catheter to provide antimicrobial properties, the device comprising:

a cap configured to be removably secured to the hub on the proximal end of the transdermal catheter;

an elongate member secured to the cap and configured for insertion into the hub of the transdermal catheter, the elongate member comprising an antimicrobial agent located along a portion of the length of the elongate member;

wherein the elongate member is configured to be retained entirely proximal to a clamp, the clamp on a proximal portion of the transdermal catheter that is distal from the hub, and the elongate member is removable from the hub by removal of the cap; and

wherein the elongate member is configured for insertion into the hub on the transdermal catheter while the clamp is closed and is retained substantially within the hub, and is configured to direct liquids radially away from the elongate member upon insertion into the hub such that liquid is directed to an exterior of the hub.

16. The device of claim 15 , wherein the antimicrobial agent comprises a coating on the elongate member.

17. The device of claim 15 , wherein the antimicrobial agent is impregnated into the elongate member.

18. The device of claim 15 , wherein the device contains a tapered portion configured to engage a tapered receiving portion on the hub of the transdermal catheter.

19. The device of claim 15 , wherein the antimicrobial agent comprises a dry antimicrobial agent.

20. The device of claim 15 , wherein the antimicrobial agent is water soluble.

21. The device of claim 15 , wherein the antimicrobial agent comprises chlorhexidine.

22. The device of claim 15 , wherein the elongate member is configured to be retained entirely within the hub of the transdermal catheter.

23. The device of claim 15 , wherein the antimicrobial agent forms a precipitate upon contact with a solution containing sodium chloride.

24. A device for insertion into a hub on a proximal end of a transdermal catheter to provide antimicrobial properties, the device comprising:

a) a cap configured to be removably secured to the hub on the proximal end of the transdermal catheter, the cap comprising:

i) an outer surface for handling the device, and

ii) an inner volume having an interior surface, the interior surface containing threads configured to engage threads on the hub on the transdermal catheter, the interior surface threads comprising an antimicrobial agent;

b) a tapered member positioned at least partially within the inner volume of the cap such that the tapered member is located opposite the threads of the cap, the tapered member having a taper of at least 5 percent; and

c) a substantially rigid elongate member secured to the tapered member and configured for insertion into the hub located on the proximal end of the transdermal catheter, the elongate member comprising the antimicrobial agent;

wherein the tapered member and the elongate member are configured for insertion into the hub located on the proximal end of the transdermal catheter, proximal to a closed clamp on a proximal portion of the transdermal catheter that is distal from the hub, such that the elongate member is retained substantially within the hub and the antimicrobial agent from the elongate member is delivered into the hub of the transdermal catheter and to the exterior threads of the transdermal catheter.

25. The device of claim 24 , wherein the antimicrobial agent comprises chlorhexidine.

26. The device of claim 24 , wherein the interior surface threads and the antimicrobial agent are configured such that the antimicrobial agent from the interior surface threads is delivered onto the threads on the hub of the transdermal catheter.

27. The device of claim 24 , wherein the tapered member and the elongate member are injection molded as a single unit.

28. The device of claim 24 , wherein the outer surface, the tapered member and the elongate member are injected molded as a single unit.

29. The device of claim 24 , wherein the tapered member comprises aft the antimicrobial agent.

30. The device of claim 29 , wherein the antimicrobial agent forms a precipitate upon contact with a solution containing sodium chloride.

Assignments (3)
SECURITY AGREEMENT Recorded Mar 31, 2022
From: ICU MEDICAL, INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 059618/0412 →
MERGER Recorded Jun 17, 2020
From: PURSUIT VASCULAR, INC.
To: ICU MEDICAL, INC.
Reel/Frame 052964/0052 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2013
From: ZIEBOL, ROBERT J.; MODERT, KEITH J.
To: PURSUIT VASCULAR, INC.
Reel/Frame 031171/0628 →
Continuity (9)
Continuation In Part 13834755 · Mar 15, 2013
Continuation In Part 13752385 · Jan 28, 2013
Continuation In Part 13915605
Continuation In Part 13547572 · Jul 12, 2012
Continuation In Part 12605966 · Oct 26, 2009
Provisional Application 61108716 · Oct 27, 2008
Provisional Application 61506979 · Jul 12, 2011
Provisional Application 61752959 · Jan 15, 2013
Related Publication 20130274686A1 · Oct 17, 2013